About us
Democratizing the application of adult stem cell technologies for human health.
Our Story
Founded in 2015, SMSbiotech is a clinical-stage biotech company. Through a combination of hard work and many decades of experience in research and applications, we discovered and named a new stem cell (Small Mobile Stem cell). With this cell we have created a new, proprietary technology that will change how the life medical industry approaches regenerative therapy. Based on our worldwide patented, revolutionary, adult stem cell research technologies, new potential treatments can be tested on multiple chronic degenerative diseases that represent a huge burden to patients and to the world economy.
The SMSbiotech platform technology will initiate a new era in regenerative medicine. SMS cell ability to proliferate extensively ex vivo without loss of potency laid the ground for industrial scale bio-manufacturing, the basis for developing alternative, more efficient, and relevant disease changing therapies.
SMSbiotech brings together a unique blend of scientific and business expertise to drive the development of innovative therapies. Our large team of leading researchers in chronic and degenerative diseases, stem cell biology, and human and veterinary medicine backed by an impressive background collaborates with business leaders to translate scientific discoveries into life-changing treatments.
Do you want to learn more about us? Contact us!
Who we are
SMSbiotech was founded based on its revolutionary adult stem cell research. Through a combination of hard work and over three decades of experience in research and applications, we have been able to patent a new platform technology.
Our technology will change the way the life science industry approaches the development of cells and drugs, leading to a wide spectrum of medical applications.
